/BNYN

BNYN Stock - Banyan Corp.

Q: What is the analyst price target for BNYN?

Analyst price target information is not currently available for BNYN.

Q: What is BNYN's market cap?

Market capitalization information is not currently available for BNYN.

Healthcare|Medical - Care Facilities|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

BUY

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for BNYN

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2003

FY2004

FY2005

FY2006

FY2007

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-4.87

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2007	FY2006	FY2005	FY2004	FY2003
Revenue	$5.00M	$5.45M	$1.09M	$465,729	$1.75M
Gross Profit	$5.00M	$5.40M	$825,139	$359,177	$664,161
Gross Margin	100.0%	99.0%	75.6%	77.1%	37.9%
Operating Income	$-1,593,882	$-351,331	$-2,521,675	$-2,207,606	$-3,802,638
Net Income	$-5,483,021	$-4,083,102	$-4,645,817	$-2,459,928	$-3,919,373
Net Margin	-109.6%	-74.9%	-425.9%	-528.2%	-223.6%
EPS	$-17.79	$-176.05	$-494.08	$-430.43	$-804.63

Company Overview

Banyan Corp., through its subsidiaries, engages in the franchising of chiropractic clinics in North America. It provides practice development training and assistance to chiropractors, as well as offers franchise support and related services to franchisees and licensees. The company also offers diagnostic testing services. Banyan Corporation provides nerve conduction velocity (NCV) testing to patients through health care professionals, such as doctors and chiropractors. The NCV testing measures the transmission of nerve impulses through the body, identifies problems in the nervous system, and enables to substantiate the cost of treatment to patients and their insurers. In addition, it manufactures and markets the VT3000, a nerve testing system for the diagnosis of neuropathies, which are diseases of the peripheral nerves and parts of the spine, as well as nerve irritation and other damage to the nervous system of a patient. The company was founded in 1978 and is based in Beverly Hills, California.

Frequently Asked Questions about BNYN

What is BNYN's current stock price?

Banyan Corp. (BNYN) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for BNYN?

No analyst price targets are currently available for this stock.

What sector is Banyan Corp. in?

Banyan Corp. operates in the Healthcare sector, specifically within the Medical - Care Facilities industry. The company is traded on the OTC exchange.

What is BNYN's market cap?

Banyan Corp. has a market capitalization of $0.00 billion, making it a small-cap company.

Does BNYN pay dividends?

No, Banyan Corp. does not currently pay a dividend to shareholders.